Impact of Donor Age on Three-Year Outcomes in Recipients of Extended Criteria Kidneys Treated with Belatacept vs Cyclosporine in BENEFIT-EXT Trial.

被引：0
作者：
Budde, K. [1 ]
Morales, J. [2 ]
Blancho, G. [3 ]
Muehlbacher, F. [4 ]
Lehner, F. [5 ]
Rice, K. [6 ]
Pupim, L.
Aigner, S.
Vincenti, F. [7 ]
机构：
[1] Charite, Berlin, Germany
[2] Hosp 12 Octubre Madrid, Madrid, Spain
[3] Univ Hosp Nantes, Nantes, France
[4] Med Univ Vienna, Vienna, Austria
[5] Hannover Med Sch, Hannover, Germany
[6] Baylor Univ, Med Ctr, Waco, TX 76798 USA
[7] Univ Calif San Francisco, San Francisco, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：182 / 183
页数：2
相关论文
共 38 条
  • [21] Three-Year Outcomes from BENEFIT: A Phase III Study of Belatacept vs Cyclosporine in Kidney Transplant Recipients
    Vincenti, F.
    Larsen, C. P.
    Alberu, J.
    Garcia, V. D.
    Rostaing, L.
    Rice, K.
    Schnitzler, M.
    Xing, J.
    Agarwal, M.
    Charpentier, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 99 - 99
  • [22] THREE-YEAR OUTCOMES FROM BENEFIT: A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS
    Vincenti, F.
    Larsen, C.
    Alberu, J.
    Garcia, V.
    Rostaing, L.
    Rice, K.
    Schnitzler, M.
    Xing, J.
    Agarwal, M.
    Charpentier, B.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 21 - 21
  • [23] THREE-YEAR OUTCOMES FROM BENEFIT: A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS
    Vincenti, Flavio
    Larsen, Christian P.
    Alberu, Josephina
    Garcia, Valter D.
    Rostaing, Lionel
    Rice, Kim
    Schnitzler, Mark
    Xing, Jun
    Agarwal, Mamta
    Charpentier, Bernard
    TRANSPLANT INTERNATIONAL, 2011, 24 : 68 - 68
  • [24] Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT
    Florman, Sander
    Vincenti, Flavio
    Durrbach, Antoine
    Abouljoud, Marwan
    Bresnahan, Barbara
    Garcia, Valter Duro
    Mulloy, Laura
    Rice, Kim
    Rostaing, Lionel
    Zayas, Carlos
    Calderon, Kellie
    Meier-Kriesche, Ulf
    Polinsky, Martin
    Yang, Lingfeng
    Pestana, Jose Medina
    Larsen, Christian P.
    CLINICAL TRANSPLANTATION, 2018, 32 (04)
  • [25] Belatacept Is Associated with Preservation of Renal Function and Structure at 1 Year Compared to Cyclosporine in Extended Criteria Donor (ECD) Kidney Transplant Patients (BENEFIT-EXT Study).
    Medina-Pestana, J. D.
    Campistol, J. M.
    Rial, M. del C.
    Garcia, V. D.
    Becker, T.
    Agarwal, M.
    Garg, P.
    Duan, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 199 - 199
  • [26] BELATACEPT IS ASSOCIATED WITH PRESERVATION OF RENAL FUNCTION AND STRUCTURE AT 1 YEAR COMPARED TO CYCLOSPORINE IN EXTENDED CRITERIA DONOR (ECD) KIDNEY TRANSPLANT PATIENTS (BENEFIT-EXT STUDY)
    Medina-Pestana, J. D.
    Campistol, J. M.
    Rial, M. del C.
    Garcia, V. D.
    Becker, T.
    Agarwal, M.
    Garg, P.
    Duan, T.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 89 - 89
  • [27] LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
    Durrbach, A.
    Bray, R.
    Gebel, H.
    Florman, S.
    Kuypers, D.
    Larsen, C. P.
    Pestana, J. Medina
    Del Carmen Rial, M.
    Rostaing, L.
    Wekerle, T.
    Meier-Kriesche, U.
    Polinsky, M.
    Townsend, R.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 8 - 8
  • [28] Long-term survival outcomes in belatacept-treated vs cyclosporine-treated patients: final results from BENEFIT-EXT
    Durrbach, Antoine
    Bray, Robert
    Gebel, Howard
    Florman, Sander
    Kuypers, Dirk
    Larsen, Christian P.
    Pestana, Jose Medina
    Del Carmen Rial, Maria
    Rostaing, Lionel
    Wekerle, Thomas
    Meier-Kriesche, Ulf
    Polinsky, Martin
    Townsend, Robert
    Grinyo, Josep
    SWISS MEDICAL WEEKLY, 2015, 145 : 41S - 41S
  • [29] Outcomes at 3-years in EBV plus Recipients of Deceased Donor Kidneys from Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
    Muehlbacher, Ferdinand
    Durrbach, Antoine
    Florman, Sander
    Pestana, Jose Medina
    Harler, Mary Beth
    Larsen, Christian
    SWISS MEDICAL WEEKLY, 2014, 144 : 23S - 23S
  • [30] Outcomes at 3-Years in EBV plus Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
    Muehlbacher, F.
    Durrbach, A.
    Florman, S.
    Medina Pestana, J.
    Harler, M.
    Larsen, C.
    TRANSPLANTATION, 2014, 98 : 455 - 455
1234